DT‐01‐05: THE USE OF SELECTIVE SPHINGOSINE‐1‐PHOSPHATE RECEPTOR 5 AGONISTS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS SUCH AS ALZHEIMER'S DISEASE AND LYSOSOMAL STORAGE DISEASES SUCH AS NIEMANN‐PICK C DISEASE. (1st July 2014)